查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088943

食品過敏診斷和治療市場：按產品類型、過敏原類型、年齡層、最終用戶和分銷管道分類－2026-2032年全球市場預測

Food Allergy Diagnostics & Therapeutics Market by Product Type, Allergen Type, Age Group, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，食品過敏診斷和治療市場將成長至 145.7 億美元，複合年成長率為 10.72%。

主要市場統計數據
基準年 2025 71.4億美元
預計年份：2026年 79.3億美元
預測年份 2032 145.7億美元
複合年成長率 (%) 10.72%

食物過敏的診斷和治療正從間歇性症狀管理轉向基於早期診斷、分子層面風險分層和標靶治療的精準過敏治療。臨床負擔十分沉重。根據美國公共衛生機構報告，約有5.8%的兒童和6.2%的成人患有食物過敏，而全球臨床文獻也一致表明，食物過敏的盛行率不斷上升，急診醫療服務的使用量增加，並對兒童和成人的生活品質造成影響。

該市場的商業決策受三個基於證據的現實所驅動。雖然口服食物激發試驗仍然是診斷的黃金標準，但皮膚點刺試驗、血清特異性IgE檢測、成分解析診斷以及新興的嗜鹼性粒細胞活化試驗正在提高區分致敏和具有臨床意義的過敏的能力。在治療方面，避免接觸過敏原和使用腎上腺素仍然是基本措施，但治療方案正在從單一過敏原脫敏療法擴展到其他療法，例如FDA已通過核准的花生口服免疫療法和用於治療IgE介導的食物過敏的Omalizumab（FDA已於2024年批准該藥）。

食物過敏領域的變革性變化

分子診斷、生物製藥療法、以患者為中心的急診護理以及更嚴格的過敏原標籤政策的融合正在重塑食物過敏的格局。在美國，根據《食品過敏快速診斷和治療法案》（FASTER Act），芝麻於2023年被列為第九大主要食物過敏原，這凸顯了相關法規對檢測小組、食品生產控制和患者教育的影響。在歐洲，14種受監管過敏原的強制標籤規定持續影響餐飲服務業、加工食品合規性和臨床諮詢。

人工智慧（AI）的累積影響

人工智慧正日益成為食物過敏診斷、臨床實踐和治療研發等各領域的重要驅動力。在診斷領域，機器學習能夠輔助識別血清特異性IgE、成分分析、患者病歷、合併氣喘、年齡、異位性皮膚炎以及先前過敏反應嚴重程度等因素的模式。經過適當檢驗後，這可以幫助臨床醫生優先安排口服食物激發試驗，並減少不必要的飲食限制。

全球食物過敏市場的關鍵區域洞察

由於都市化、飲食多樣化、兒童過敏意識的提高以及私人診斷服務的擴張，亞太地區對IgE檢測和專業過敏服務的需求不斷成長，因此該地區正成為重點發展區域。日本、中國、韓國、印度和澳洲尤其重要，因為這些國家擁有大規模的兒童人口、成熟的醫療保健體系，並且不斷增加對免疫學、數位醫療和檢測基礎設施的投資。尤其是在澳大利亞，鑑於兒童食物過敏的高發生率以及全國範圍內的過敏管理舉措，食物過敏正受到臨床和公共衛生領域的廣泛關注。

策略市場擴張的關鍵群洞察

由於新加坡、馬來西亞、泰國、印尼、越南和菲律賓等兒童醫療保健、私人診斷和醫院過敏相關服務的擴張，東協市場的重要性日益凸顯。在這些地區，中產階級的壯大推動了專科諮詢服務的普及，加之餐飲服務業的全球化，使得可靠的過敏原風險管理、對加工食品標籤的認知以及學校緊急時應對計畫的需求不斷成長，因此市場需求最為強勁。

來自重點食物過敏市場主要國家的洞察

美國憑藉著較高的公眾意識、FDA的監管、嚴格的芝麻過敏標籤法規、已通過核准的花生口服免疫療法以及2024年獲批用於治療一種或多種IgE介導的食物過敏的Omalizumab，在全球芝麻過敏商業化領域處於領先地位。加拿大擁有完善的公共衛生指南，並且在都市區能夠方便地獲得專科醫生的服務。同時，墨西哥和巴西正在拉丁美洲擴展其醫療保健體系，不斷增加私人診斷中心、兒童過敏服務和都市區醫院的數量。

為行業領導者提供的實用建議

產業領導者應優先考慮整合式醫療模式，將檢驗的診斷、風險分層、病患教育、腎上腺素取得途徑和治療監測相結合。將檢測作為循證治療決策的途徑的機構，將比那些僅提供檢測或一次性干預的機構更具優勢。

調查方法與證據框架

本執行摘要是基於對食物過敏診斷、治療、監管趨勢、臨床指南、公共衛生資料集和技術應用模式的實證評估。調查方法強調檢驗的資訊來源，包括國家公共衛生機構、監管機構、同行評審的過敏和免疫學文獻、臨床試驗記錄、藥物安全監測更新以及權威專家的指導意見。

結論：精準過敏醫學將為下一階段鋪路。

食物過敏的診斷和治療已進入一個更為成熟的階段，其特點是檢測手段更加精細、免疫調節療法獲得批准、緊急治療方案得到改進以及以數據為導向的診療路徑得以建立。最大的發展機會在於精準診斷、可衡量的臨床結果、合規監管以及以患者為中心的醫療服務這四者之間的平衡。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 食品過敏診斷與治療市場：依產品類型分類

  • 診斷測試
    • 居家過敏測試
    • 成分分解診斷
    • 皮膚點刺試驗
    • 特異性IgE檢測
  • 治療產品
    • 抗組織胺藥
    • 緊急治療
    • 免疫療法
      • 經皮免疫療法
      • 口服免疫療法
      • 皮下免疫療法
    • 單株抗體

第8章：食物過敏診斷與治療市場：依過敏原類型分類

  • 雞蛋過敏
  • 魚類過敏
  • 牛奶過敏
  • 花生過敏
  • 芝麻過敏
  • 貝類過敏
  • 大豆過敏
  • 堅果過敏
  • 小麥過敏

第9章：食物過敏診斷與治療市場：依年齡層分類

  • 兒童
  • 成人
  • 老年人

第10章：食物過敏診斷與治療市場：依最終使用者分類

  • 醫院實驗室
  • 照護端環境
  • 參考實驗室
  • 研究機構

第11章 食品過敏診斷與治療市場：依通路分類

  • 診所和診斷中心
  • 醫院
  • 線上
  • 藥局

第12章 食品過敏診斷與治療市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：食物過敏診斷與治療市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 食品過敏診斷與治療市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • ALK-Abello A/S
  • Allergy Therapeutics plc
  • bioMerieux SA
  • DBV Technologies SA
  • Eurofins Scientific SE
  • HAL Allergy Group
  • HOB Biotech Group Corp. Ltd.
  • HYCOR Biomedical
  • Immunomic Therapeutics Inc.
  • Lincoln Diagnostics Inc.
  • Medeca Pharma AB
  • NEOGEN Corporation
  • Nestle Health Science SA
  • Omega Diagnostics Group PLC
  • Pfizer Inc.
  • Prota Therapeutics Pty Ltd
  • Quest Diagnostics Incorporated
  • R-Biopharm AG
  • Sanofi SA
  • Siemens Healthineers AG
  • Stallergenes Greer International SA
  • Thermo Fisher Scientific Inc.
Product Code: MRR-ED54C46E8118

The Food Allergy Diagnostics & Therapeutics Market is projected to grow by USD 14.57 billion at a CAGR of 10.72% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.14 billion
Estimated Year [2026] USD 7.93 billion
Forecast Year [2032] USD 14.57 billion
CAGR (%) 10.72%

Food allergy diagnostics and therapeutics are moving from episodic symptom management toward precision allergy care built on earlier diagnosis, molecular risk stratification, and targeted treatment. The clinical burden is significant: U.S. public health sources report food allergy in approximately 5.8% of children and 6.2% of adults, while global clinical literature consistently identifies rising prevalence, substantial emergency-care utilization, and quality-of-life impact across pediatric and adult populations.

Executive decision-making in this market is shaped by three evidence-based realities. Oral food challenge remains the diagnostic reference standard, but skin-prick testing, serum-specific IgE testing, component-resolved diagnostics, and emerging basophil activation testing are improving the ability to distinguish sensitization from clinically meaningful allergy. On the therapeutic side, avoidance and epinephrine remain foundational, while FDA-approved peanut oral immunotherapy and the 2024 FDA approval of omalizumab for IgE-mediated food allergy have expanded the treatment framework beyond single-allergen desensitization.

Transformative Shifts in the Food Allergy Landscape

The landscape is being reshaped by the convergence of molecular diagnostics, biologic therapy, patient-centered emergency treatment, and stricter allergen-labeling policy. In the United States, sesame became the ninth major food allergen under the FASTER Act in 2023, reinforcing how regulation is influencing testing panels, food manufacturing controls, and patient education. In Europe, mandatory disclosure of 14 regulated allergens continues to shape foodservice, packaged food compliance, and clinical counseling.

Clinically, the market is shifting from broad avoidance advice to quantified risk assessment. Component-resolved diagnostics are helping clinicians evaluate peanut, tree nut, milk, egg, wheat, and shellfish sensitization patterns, while digital symptom tracking and connected care models are improving follow-up. Therapeutics are also diversifying as oral immunotherapy, biologics, epicutaneous approaches, sublingual approaches, and improved epinephrine delivery formats create new opportunities for integrated diagnostic-treatment pathways.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a practical accelerator across food allergy diagnostics, clinical operations, and therapeutic development. In diagnostics, machine learning can support pattern recognition across serum-specific IgE, component testing, patient history, comorbid asthma, age, atopic dermatitis, and prior reaction severity, helping clinicians prioritize oral food challenges and reduce unnecessary dietary restriction when appropriately validated.

AI also improves trial design and real-world evidence generation by identifying eligible cohorts, modeling responder profiles, and analyzing longitudinal adherence data for oral immunotherapy and biologic use. For industry leaders, the most defensible AI strategies will be those built on transparent algorithms, diverse datasets, clinician oversight, explainable outputs, and compliance with medical device, data privacy, and health equity requirements.

Key Regional Insights Across Global Food Allergy Markets

Asia-Pacific is emerging as a high-priority region as urbanization, dietary diversification, pediatric allergy awareness, and expanding private diagnostics increase demand for IgE testing and specialist allergy services. Japan, China, South Korea, India, and Australia are particularly important because they combine large pediatric populations or mature healthcare systems with rising investment in immunology, digital health, and laboratory infrastructure. Australia also has extensive clinical and public health attention on food allergy due to well-documented pediatric prevalence and national allergy management initiatives.

North America remains the most advanced commercial environment due to high diagnosis rates, established allergist networks, FDA-cleared diagnostic platforms, food-labeling enforcement, school and emergency anaphylaxis protocols, and rapid uptake of approved therapies. Europe is characterized by strong clinical guidelines, the European Union's mandatory labeling of 14 major allergens, established immunology research networks, and broad adoption of evidence-based allergy management through national health systems. Latin America, the Middle East, and Africa are earlier in market maturity, with adoption tied to urban hospital networks, private laboratories, medical tourism hubs, pediatric care expansion, clinician education, and gradual improvements in emergency anaphylaxis preparedness.

Key Group Insights for Strategic Market Expansion

ASEAN markets are gaining relevance as Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines expand pediatric care, private diagnostics, and hospital-based allergy services. Demand is strongest where middle-class growth supports specialist consultations and where foodservice globalization increases the need for reliable allergen risk management, packaged food labeling awareness, and school-based emergency response planning.

The GCC is investing in advanced healthcare infrastructure, specialty clinics, and imported diagnostic technologies, creating favorable conditions for premium allergy testing, biologic therapy adoption, and tertiary-care allergy programs. The European Union provides one of the world's most structured allergy environments through harmonized food-labeling rules, pharmacovigilance systems, and guideline-driven care. BRICS economies combine large patient pools with uneven access, making scalable diagnostics, clinician training, and affordable emergency treatment central to growth. G7 countries lead in regulatory sophistication, reimbursement depth, clinical research, and patient advocacy, while NATO-aligned markets benefit indirectly from resilient medical supply chains, emergency preparedness frameworks, and coordinated health security planning.

Key Country Insights in Priority Food Allergy Markets

The United States leads global commercialization through high awareness, FDA oversight, sesame-labeling enforcement, approved peanut oral immunotherapy, and the 2024 approval of omalizumab for one or more IgE-mediated food allergies. Canada has strong public health guidance and specialist care access in urban centers, while Mexico and Brazil represent expanding Latin American opportunities as private diagnostics, pediatric allergy services, and urban hospital capabilities grow.

In Europe, the United Kingdom, Germany, France, Italy, and Spain benefit from robust guideline adoption, established allergology networks, emergency anaphylaxis guidance, and mandatory allergen disclosure, while Russia shows demand in major urban centers despite access variability. China and India offer scale, increasing hospital investment, expanding laboratory capacity, and rising allergy awareness, though access remains uneven outside major cities. Japan, Australia, and South Korea are mature Asia-Pacific markets with strong clinical practice standards, sophisticated diagnostics, established pediatric care pathways, and growing interest in precision immunology.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize integrated care models that connect validated diagnostics, risk stratification, patient education, epinephrine access, and therapy monitoring. Organizations that position testing as a gateway to evidence-based treatment decisions will be better placed than those offering isolated assays or single-point interventions.

Executives should invest in real-world evidence, health-economic studies, and workflow integration for allergists, pediatricians, emergency departments, dietitians, and primary care. Commercial teams should tailor strategies by market maturity: advanced economies require differentiation through precision diagnostics, patient support, and biologic pathway support, while emerging markets need affordable testing, clinician training, cold-chain reliability, supply continuity, and patient education on anaphylaxis recognition.

Research Methodology and Evidence Framework

This executive summary is built from an evidence-led assessment of food allergy diagnostics, therapeutics, regulatory developments, clinical guidelines, public health datasets, and technology adoption patterns. The methodology emphasizes verified sources such as national public health agencies, regulatory authorities, peer-reviewed allergy and immunology literature, clinical trial records, pharmacovigilance updates, and recognized professional guidance.

The analysis triangulates disease burden, diagnostic standards, therapeutic approvals, regional healthcare capacity, allergen-labeling policy, emergency treatment readiness, and commercial adoption conditions. Qualitative insights were structured around clinical utility, reimbursement feasibility, regulatory risk, adoption barriers, health equity, and scalability across hospital, laboratory, specialty clinic, primary care, school, and home-care settings.

Conclusion: Precision Allergy Care Is Defining the Next Phase

Food allergy diagnostics and therapeutics are entering a more sophisticated phase defined by precision testing, approved immunomodulatory therapy, improved emergency treatment options, and data-enabled care pathways. The strongest opportunities sit at the intersection of accurate diagnosis, measurable clinical outcomes, regulatory compliance, and patient-centered treatment access.

Organizations that combine scientific credibility with scalable delivery will be best positioned to lead. Success will depend on validating AI tools, demonstrating cost-effectiveness, supporting clinician adoption, improving patient adherence, and aligning product strategy with regional regulatory, reimbursement, and infrastructure realities.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Food Allergy Diagnostics & Therapeutics Market, by Product Type

  • 7.1. Diagnostic Tests
    • 7.1.1. At-Home Allergy Tests
    • 7.1.2. Component Resolved Diagnostics
    • 7.1.3. Skin Prick Tests
    • 7.1.4. Specific IgE Tests
  • 7.2. Therapeutic Products
    • 7.2.1. Antihistamines
    • 7.2.2. Emergency Treatments
    • 7.2.3. Immunotherapy
      • 7.2.3.1. Epicutaneous Immunotherapy
      • 7.2.3.2. Oral Immunotherapy
      • 7.2.3.3. Subcutaneous Immunotherapy
    • 7.2.4. Monoclonal Antibodies

8. Food Allergy Diagnostics & Therapeutics Market, by Allergen Type

  • 8.1. Egg Allergy
  • 8.2. Fish Allergy
  • 8.3. Milk Allergy
  • 8.4. Peanut Allergy
  • 8.5. Sesame Allergy
  • 8.6. Shellfish Allergy
  • 8.7. Soy Allergy
  • 8.8. Tree Nut Allergy
  • 8.9. Wheat Allergy

9. Food Allergy Diagnostics & Therapeutics Market, by Age Group

  • 9.1. Pediatric
  • 9.2. Adults
  • 9.3. Geriatric

10. Food Allergy Diagnostics & Therapeutics Market, by End User

  • 10.1. Hospital Laboratories
  • 10.2. Point-Of-Care Settings
  • 10.3. Reference Laboratories
  • 10.4. Research Institutes

11. Food Allergy Diagnostics & Therapeutics Market, by Distribution Channel

  • 11.1. Clinics & Diagnostic Centers
  • 11.2. Hospitals
  • 11.3. Online
  • 11.4. Pharmacies

12. Food Allergy Diagnostics & Therapeutics Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Food Allergy Diagnostics & Therapeutics Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Food Allergy Diagnostics & Therapeutics Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. ALK-Abello A/S
  • 16.2. Allergy Therapeutics plc
  • 16.3. bioMerieux SA
  • 16.4. DBV Technologies S.A.
  • 16.5. Eurofins Scientific SE
  • 16.6. HAL Allergy Group
  • 16.7. HOB Biotech Group Corp. Ltd.
  • 16.8. HYCOR Biomedical
  • 16.9. Immunomic Therapeutics Inc.
  • 16.10. Lincoln Diagnostics Inc.
  • 16.11. Medeca Pharma AB
  • 16.12. NEOGEN Corporation
  • 16.13. Nestle Health Science S.A.
  • 16.14. Omega Diagnostics Group PLC
  • 16.15. Pfizer Inc.
  • 16.16. Prota Therapeutics Pty Ltd
  • 16.17. Quest Diagnostics Incorporated
  • 16.18. R-Biopharm AG
  • 16.19. Sanofi S.A.
  • 16.20. Siemens Healthineers AG
  • 16.21. Stallergenes Greer International S.A.
  • 16.22. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DIAGNOSTIC TESTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DIAGNOSTIC TESTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DIAGNOSTIC TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AT-HOME ALLERGY TESTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AT-HOME ALLERGY TESTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AT-HOME ALLERGY TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL COMPONENT RESOLVED DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL COMPONENT RESOLVED DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL COMPONENT RESOLVED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SKIN PRICK TESTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SKIN PRICK TESTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SKIN PRICK TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SPECIFIC IGE TESTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SPECIFIC IGE TESTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SPECIFIC IGE TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL THERAPEUTIC PRODUCTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL THERAPEUTIC PRODUCTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL THERAPEUTIC PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANTIHISTAMINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ANTIHISTAMINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANTIHISTAMINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL EMERGENCY TREATMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL EMERGENCY TREATMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL EMERGENCY TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL IMMUNOTHERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL IMMUNOTHERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL EPICUTANEOUS IMMUNOTHERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL EPICUTANEOUS IMMUNOTHERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL EPICUTANEOUS IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ORAL IMMUNOTHERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ORAL IMMUNOTHERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ORAL IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SUBCUTANEOUS IMMUNOTHERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SUBCUTANEOUS IMMUNOTHERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SUBCUTANEOUS IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL EGG ALLERGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL EGG ALLERGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL EGG ALLERGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FISH ALLERGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL FISH ALLERGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FISH ALLERGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MILK ALLERGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MILK ALLERGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MILK ALLERGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PEANUT ALLERGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PEANUT ALLERGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PEANUT ALLERGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SESAME ALLERGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SESAME ALLERGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SESAME ALLERGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SHELLFISH ALLERGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SHELLFISH ALLERGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SHELLFISH ALLERGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SOY ALLERGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SOY ALLERGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SOY ALLERGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL TREE NUT ALLERGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL TREE NUT ALLERGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL TREE NUT ALLERGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL WHEAT ALLERGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL WHEAT ALLERGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL WHEAT ALLERGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ADULTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ADULTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ADULTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HOSPITAL LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HOSPITAL LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HOSPITAL LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL POINT-OF-CARE SETTINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL POINT-OF-CARE SETTINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL POINT-OF-CARE SETTINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CLINICS & DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CLINICS & DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CLINICS & DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. GCC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 172. GCC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. GCC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 174. GCC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 175. GCC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 176. GCC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. GCC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 178. GCC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. GCC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 198. G7 FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 199. G7 FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. G7 FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 201. G7 FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 202. G7 FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 203. G7 FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. G7 FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 205. G7 FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. G7 FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 207. NATO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 208. NATO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. NATO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 210. NATO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 211. NATO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 212. NATO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. NATO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 214. NATO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. NATO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 226. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 229. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 230. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 231. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 233. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 235. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 238. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 239. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 240. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 242. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 244. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 247. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 248. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 249. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 251. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED KINGDOM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED KINGDOM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED KINGDOM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED KINGDOM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED KINGDOM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED KINGDOM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED KINGDOM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED KINGDOM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED KINGDOM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 262. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 265. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 266. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 267. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 269. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 270. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 271. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 272. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 274. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 275. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 276. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 278. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 280. RUSSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 281. RUSSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. RUSSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 283. RUSSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 284. RUSSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 285. RUSSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. RUSSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 287. RUSSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 288. RUSSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 289. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 290. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 292. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 293. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 294. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 296. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 297. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 298. SPAIN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 299. SPAIN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. SPAIN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 301. SPAIN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 302. SPAIN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 303. SPAIN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 304. SPAIN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 305. SPAIN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 306. SPAIN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 307. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 308. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 310. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 311. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 312. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 313. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 314. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 315. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 316. INDIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 317. INDIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (